Haverford Trust CO Novartis Ag Transaction History

Haverford Trust CO

  • $9.59 Billion
  • Q1 2025

A detailed history of Haverford Trust CO transactions in Novartis Ag stock. As of the latest transaction made, Haverford Trust CO holds 37,265 shares of NVS stock, worth $4.47 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares
37,265
Previous 37,939 1.78%
Holding current value
$4.47 Million
Previous $3.69 Million 12.54%
% of portfolio
0.04%
Previous 0.04%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

May 14, 2025
SELL
$97.14 - $115.57 $65,472 - $77,894
-674 Reduced 1.78%
37,265 $4.15 Million
Q4 2024

Feb 11, 2025
BUY
$96.78 - $117.18 $49,938 - $60,464
516 Added 1.38%
37,939 $3.69 Million
Q3 2024

Nov 05, 2024
BUY
$106.13 - $120.89 $79,172 - $90,183
746 Added 2.03%
37,423 $4.3 Million
Q2 2024

Aug 13, 2024
SELL
$92.57 - $107.37 $107,936 - $125,193
-1,166 Reduced 3.08%
36,677 $3.9 Million
Q1 2024

May 02, 2024
BUY
$95.27 - $108.47 $288,382 - $328,338
3,027 Added 8.69%
37,843 $3.66 Million
Q4 2023

Feb 08, 2024
BUY
$92.27 - $101.54 $330,880 - $364,122
3,586 Added 11.48%
34,816 $3.52 Million
Q3 2023

Nov 09, 2023
SELL
$94.73 - $105.13 $8,430 - $9,356
-89 Reduced 0.28%
31,230 $3.18 Million
Q2 2023

Aug 08, 2023
SELL
$92.52 - $104.91 $221,770 - $251,469
-2,397 Reduced 7.11%
31,319 $3.16 Million
Q1 2023

May 12, 2023
BUY
$80.03 - $92.81 $130,528 - $151,373
1,631 Added 5.08%
33,716 $3.1 Million
Q4 2022

Feb 13, 2023
SELL
$75.55 - $92.52 $31,277 - $38,303
-414 Reduced 1.27%
32,085 $2.91 Million
Q2 2022

Aug 12, 2022
SELL
$80.52 - $93.75 $5,314 - $6,187
-66 Reduced 0.2%
32,499 $2.75 Million
Q1 2022

May 05, 2022
SELL
$80.11 - $90.62 $804,704 - $910,277
-10,045 Reduced 23.57%
32,565 $2.86 Million
Q3 2021

Nov 12, 2021
SELL
$81.78 - $95.14 $610,896 - $710,695
-7,470 Reduced 14.92%
42,610 $3.49 Million
Q2 2021

Aug 16, 2021
SELL
$85.24 - $94.15 $3.68 Million - $4.07 Million
-43,211 Reduced 90.44%
4,569 $4.57 Million
Q2 2021

Aug 16, 2021
BUY
$85.24 - $94.15 $3.88 Million - $4.28 Million
45,511 Added 996.08%
50,080 $4.57 Million
Q1 2021

May 12, 2021
BUY
$83.5 - $98.47 $754,589 - $889,873
9,037 Added 23.33%
47,780 $4.08 Million
Q4 2020

Feb 05, 2021
BUY
$78.07 - $94.43 $327,894 - $396,606
4,200 Added 12.16%
38,743 $3.66 Million
Q3 2020

Nov 10, 2020
SELL
$82.14 - $91.0 $53,637 - $59,423
-653 Reduced 1.86%
34,543 $3 Million
Q2 2020

Aug 13, 2020
BUY
$80.93 - $91.1 $1,618 - $1,822
20 Added 0.06%
35,196 $3.07 Million
Q1 2020

May 11, 2020
BUY
$70.67 - $99.01 $606,984 - $850,396
8,589 Added 32.31%
35,176 $2.9 Million
Q3 2019

Nov 04, 2019
SELL
$85.54 - $94.26 $59,878 - $65,982
-700 Reduced 2.57%
26,587 $2.31 Million
Q2 2019

Aug 13, 2019
SELL
$75.4 - $92.8 $1,960 - $2,412
-26 Reduced 0.1%
27,287 $2.49 Million
Q1 2019

May 09, 2019
SELL
$75.32 - $86.15 $14,838 - $16,971
-197 Reduced 0.72%
27,313 $2.63 Million
Q4 2018

Feb 12, 2019
BUY
$73.66 - $82.02 $45,742 - $50,934
621 Added 2.31%
27,510 $2.36 Million
Q3 2018

Nov 08, 2018
BUY
$66.94 - $77.43 $669 - $774
10 Added 0.04%
26,889 $2.32 Million
Q2 2018

Aug 10, 2018
SELL
$64.91 - $73.36 $395,172 - $446,615
-6,088 Reduced 18.47%
26,879 $2.03 Million
Q1 2018

May 09, 2018
BUY
$70.39 - $84.15 $85,453 - $102,158
1,214 Added 3.82%
32,967 $2.67 Million
Q4 2017

Feb 13, 2018
BUY
$72.33 - $77.64 $21,915 - $23,524
303 Added 0.96%
31,753 $2.67 Million
Q3 2017

Nov 09, 2017
BUY
$74.14 - $77.27 $4,967 - $5,177
67 Added 0.21%
31,450 $2.7 Million
Q2 2017

Aug 14, 2017
BUY
N/A
31,383
31,383 $2.62 Million

Others Institutions Holding NVS

# of Institutions
1,522
Shares Held
142M
Call Options Held
1.63M
Put Options Held
1.82M
View Full List

About NOVARTIS AG

NVS Quotes by TradingView
  • Ticker NVS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,151,000,064
  • Market Cap $258B
  • Description
  • Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...
More about NVS
Track This Portfolio

Track Haverford Trust CO Portfolio

Follow Haverford Trust CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Haverford Trust CO, based on Form 13F filings with the SEC.

News

Stay updated on Haverford Trust CO with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email